Found: 44
Select item for more details and to access through your institution.
Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-03706-w
- By:
- Publication type:
- Article
Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis C.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 12, p. 4517, doi. 10.3390/ijms21124517
- By:
- Publication type:
- Article
Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 5, p. 962, doi. 10.3390/ijms18050962
- By:
- Publication type:
- Article
Outcome of nucleos(t)ide analog intervention in patients with preventive or on‐demand therapy for hepatitis B virus reactivation.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 6, p. 3679, doi. 10.1002/jmv.26526
- By:
- Publication type:
- Article
Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-03706-w
- By:
- Publication type:
- Article
The Albumin-bilirubin Score Detects Changes in the Liver Function during Treatment for Budd-Chiari Syndrome: A Retrospective Observational Study.
- Published in:
- Internal Medicine, 2022, v. 61, n. 7, p. 959, doi. 10.2169/internalmedicine.8020-21
- By:
- Publication type:
- Article
Sofosbuvir/Velpatasvir Plus Ribavirin Combination Therapy for Patients with Hepatitis C Virus Genotype 1a, 2a, or 3b after Glecaprevir/Pibrentasvir Therapy Failed.
- Published in:
- Internal Medicine, 2021, v. 60, n. 21, p. 3441, doi. 10.2169/internalmedicine.7028-21
- By:
- Publication type:
- Article
Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy.
- Published in:
- Hepatology Research, 2024, v. 54, n. 7, p. 615, doi. 10.1111/hepr.14016
- By:
- Publication type:
- Article
Postoperative direct‐acting antiviral treatment after liver resection in patients with hepatitis C virus‐related hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1102, doi. 10.1111/hepr.13709
- By:
- Publication type:
- Article
Assessing liver stiffness with conventional cut‐off values overestimates liver fibrosis staging in patients who received the Fontan procedure.
- Published in:
- Hepatology Research, 2021, v. 51, n. 5, p. 593, doi. 10.1111/hepr.13627
- By:
- Publication type:
- Article
Sequential therapy involving an early switch from entecavir to pegylated interferon‐α in Japanese patients with chronic hepatitis B.
- Published in:
- Hepatology Research, 2018, v. 48, n. 6, p. 459, doi. 10.1111/hepr.13050
- By:
- Publication type:
- Article
Randomized trial of combined triple therapy comprising two types of peginterferon with simeprevir in patients with hepatitis C virus genotype 1b.
- Published in:
- Hepatology Research, 2016, v. 46, n. 13, p. 1311, doi. 10.1111/hepr.12689
- By:
- Publication type:
- Article
Outcomes of laparoscopic hepatic resection versus percutaneous radiofrequency ablation for hepatocellular carcinoma located at the liver surface: A case-control study with propensity score matching.
- Published in:
- Hepatology Research, 2016, v. 46, n. 6, p. 565, doi. 10.1111/hepr.12592
- By:
- Publication type:
- Article
MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy.
- Published in:
- Hepatology Research, 2016, v. 46, n. 3, p. E26, doi. 10.1111/hepr.12518
- By:
- Publication type:
- Article
Effect of Caffeine-Containing Beverage Consumption on Serum Alanine Aminotransferase Levels in Patients with Chronic Hepatitis C Virus Infection: A Hospital-Based Cohort Study.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0083382
- By:
- Publication type:
- Article
Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2045, doi. 10.3390/cancers12082045
- By:
- Publication type:
- Article
A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257166
- By:
- Publication type:
- Article
Transcatheter Arterial Chemoembolization for Treatment-Naive Hepatocellular Carcinoma Has Different Treatment Effects Depending on Central or Peripheral Tumor Location.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 576, doi. 10.1159/000530441
- By:
- Publication type:
- Article
Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-60440-5
- By:
- Publication type:
- Article
Association of serum autotaxin levels with liver fibrosis in patients pretreatment and posttreatment with chronic hepatitis C.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 1, p. 217, doi. 10.1111/jgh.15114
- By:
- Publication type:
- Article
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2020, v. 19, n. 4, p. 367, doi. 10.1016/j.aohep.2020.04.002
- By:
- Publication type:
- Article
Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2017, v. 16, n. 5, p. 734, doi. 10.5604/01.3001.0010.2732
- By:
- Publication type:
- Article
Effects on anemia of drug adjustment in patients with chronic hepatitis C during telaprevir-combined therapy.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2015, v. 14, n. 1, p. 28, doi. 10.1016/s1665-2681(19)30798-7
- By:
- Publication type:
- Article
Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93435-x
- By:
- Publication type:
- Article
Circulating Exosomal miRNA Profiles Predict the Occurrence and Recurrence of Hepatocellular Carcinoma in Patients with Direct-Acting Antiviral-Induced Sustained Viral Response.
- Published in:
- Biomedicines, 2019, v. 7, n. 4, p. 87, doi. 10.3390/biomedicines7040087
- By:
- Publication type:
- Article
Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis.
- Published in:
- Journal of Gastroenterology, 2023, v. 58, n. 4, p. 394, doi. 10.1007/s00535-023-01963-2
- By:
- Publication type:
- Article
Lenvatinib-Induced Tumor-Related Hemorrhages in Patients with Large Hepatocellular Carcinomas.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 186, doi. 10.1159/000510911
- By:
- Publication type:
- Article
Per‐rectal portal scintigraphy as an alternative measure of hepatic venous pressure gradient in chronic liver disease: A preliminary report.
- Published in:
- Clinical Physiology & Functional Imaging, 2021, v. 41, n. 4, p. 334, doi. 10.1111/cpf.12703
- By:
- Publication type:
- Article
Risk factors for liver‐related and non‐liver‐related mortality following a sustained virological response after direct‐acting antiviral treatment for hepatitis C virus infection in a real‐world cohort.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 5, p. 374, doi. 10.1111/jvh.13795
- By:
- Publication type:
- Article
Direct‐acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 1, p. 52, doi. 10.1111/jvh.13627
- By:
- Publication type:
- Article
Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21.
- Published in:
- FEBS Open Bio, 2022, v. 12, n. 12, p. 2122, doi. 10.1002/2211-5463.13489
- By:
- Publication type:
- Article
Correction: Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma.
- Published in:
- JGH Open, 2022, v. 6, n. 11, p. 754, doi. 10.1002/jgh3.12819
- By:
- Publication type:
- Article
Validation of a two‐step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis.
- Published in:
- JGH Open, 2021, v. 5, n. 7, p. 801, doi. 10.1002/jgh3.12590
- By:
- Publication type:
- Article
High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug use.
- Published in:
- JGH Open, 2020, v. 4, n. 5, p. 964, doi. 10.1002/jgh3.12376
- By:
- Publication type:
- Article
Cytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species.
- Published in:
- Oncogenesis, 2022, v. 11, n. 1, p. 1, doi. 10.1038/s41389-022-00389-4
- By:
- Publication type:
- Article
Association between HLA‐DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 5, p. 937, doi. 10.1111/jgh.14454
- By:
- Publication type:
- Article
Correlation between polymorphism in the inosine triphosphatase and the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy.
- Published in:
- Journal of Gastroenterology & Hepatology, 2017, v. 32, n. 8, p. 1495, doi. 10.1111/jgh.13743
- By:
- Publication type:
- Article
Prospective long-term study of hepatitis B virus reactivation in patients with hematologic malignancy.
- Published in:
- Journal of Gastroenterology & Hepatology, 2014, v. 29, n. 9, p. 1715, doi. 10.1111/jgh.12604
- By:
- Publication type:
- Article
Positioning of <sup>18</sup>F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2014, v. 29, n. 9, p. 1722, doi. 10.1111/jgh.12611
- By:
- Publication type:
- Article
Relationship between inosine triphosphate genotype and outcome of extended therapy in hepatitis C virus patients with a late viral response to pegylated-interferon and ribavirin.
- Published in:
- Journal of Gastroenterology & Hepatology, 2014, v. 29, n. 1, p. 201, doi. 10.1111/jgh.12376
- By:
- Publication type:
- Article
Severity of Liver Fibrosis Is Associated with the Japanese Diet Pattern and Skeletal Muscle Mass in Patients with Nonalcoholic Fatty Liver Disease.
- Published in:
- Nutrients, 2023, v. 15, n. 5, p. 1175, doi. 10.3390/nu15051175
- By:
- Publication type:
- Article
Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0194163
- By:
- Publication type:
- Article